Publications
Westat researchers publish on a wide array of topics that further our understanding of the field and focus on improving lives through research. Selected publications that communicate our findings, including books, peer-reviewed articles and technical reports, conference proceedings, and more are presented here.
2021
Thompson M.G., Stenehjem E., Grannis S., Ball S.W., Naleway A.L., Ong T.C., DeSilva M.B., Natarajan K., Bozio C.H., Lewis N., Dascomb K., Dixon B.E., Birch R.J., Irving S.A., Rao S., Kharbanda E., Han J., Reynolds S., Goddard K., Grisel N., Fadel W.F., Levy M.E., Ferdinands J., Fireman B., Arndorfer J., Valvi N.R., Rowley E.A., Patel P., Zerbo O., Griggs E.P., Porter R.M., Demarco M., Blanton L., Steffens A., Zhuang Y., Olson N., Barron M., Shifflett P., Schrag S.J., Verani J.R., Fry A., Gaglani M., Azziz-Baumgartner E., and Klein N.P. (2021).
Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings.
New England Journal of Medicine, 385(15), 1355-1371.
Zhang T., Joubert P., Ansari-Pour N., Zhao W., Hoang P.H., Lokanga R., Moye A.L., Rosenbaum J., Gonzalez-Perez A., Martínez-Jiménez F., Castro A., Muscarella L.A., Hofman P., Consonni D., Pesatori A.C., Kebede M., Li M., Gould Rothberg B.E., Peneva I., Schabath M.B., Poeta M.L., Costantini M., Hirsch D., Heselmeyer-Haddad K., Hutchinson A., Olanich M., Lawrence S.M., Lenz P., Duggan M., Bhawsar P.M.S., Sang J., Kim J., Mendoza L., Saini N., Klimczak L.J., Islam S.M.A., Otlu B., Khandekar A., Cole N., Stewart D.R., Choi J., Brown K.M., Caporaso N.E., Wilson S.H., Pommier Y., Lan Q., Rothman N., Almeida J.S., Carter H., Ried T., Kim C.F., Lopez-Bigas N., Garcia-Closas M., Shi J., Bossé Y., Zhu B., Gordenin D.A., Alexandrov L.B., Chanock S.J., Wedge D.C., and Landi M.T. (2021).
Genomic and evolutionary classification of lung cancer in never smokers.
Nature Genetics, 53(9), 1348-1359.
Embi P.J., Levy M.E., Naleway A.L., Patel P., Gaglani M., Natarajan K., Dascomb K., Ong T.C., Klein N.P., Liao I.-C., Grannis S.J., Han J., Stenehjem E., Dunne M.M., Lewis N., Irving S.A., Rao S., McEvoy C., Bozio C.H., Murthy K., Dixon B.E., Grisel N., Yang D.-H., Goddard K., Kharbanda A.B., Reynolds S., Raiyani C., Fadel W.F., Arndorfer J., Rowley E.A., Fireman B., Ferdinands J., Valvi N.R., Ball S.W., Zerbo O., Griggs E.P., Mitchell P.K., Porter R.M., Kiduko S.A., Blanton L., Zhuang Y., Steffens A., Reese S.E., Olson N., Williams J., Dickerson M., McMorrow M., Schrag S.J., Verani J.R., Fry A.M., Azziz-Baumgartner E., Barron M.A., Thompson M.G., and DeSilva M.B. (2021).
Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults — Nine states, January–September 2021.
Morbidity and Mortality Weekly Report, 70(44), 1553-1559.
Xia B., Blount B.C., Guillot T., Brosius C., Li Y., van Bemmel D.M., Kimmel H.L., Chang C.M., Borek N., Edwards K.C., Lawrence C., Hyland A., Goniewicz M.L., Pine B.N., Xia Y., Bernert J.T., de Castro B.R., Lee J., Brown J.L., Arnstein S., Choi D., Wade E.L., Hatsukami D., Ervies G., Cobos A., Nicodemus K., Freeman D., Hecht S.S., Conway K., and Wang L. (2021).
Tobacco-specific nitrosamines (NNAL, NNN, NAT, and NAB) exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013–2014).
Nicotine and Tobacco Research, 23(3), 573-583.
Edwards K.C., Naz T., Stanton C.A., Goniewicz M.L., Hatsukami D.K., Smith D.M., Wang L., Villanti A., Pearson J., Blount B.C., Bansal-Travers M., Feng J., Niaura R., Manderski M.T.B., Sosnoff C.S., Delnevo C.D., Duffy K., Del Valle-Pinero A.Y., Rostron B.L., Everard C., Kimmel H.L., van Bemmel D.M., and Hyland A. (2021).
Urinary cotinine and cotinine + trans-3'-hydroxycotinine (TNE-2) cut-points for distinguishing tobacco use from nonuse in the United States: PATH Study (2013–2014).
Cancer Epidemiology, Biomarkers and Prevention, 30(6), 1175-1184.
Sosnoff C.S., Caron K., Akins J.R., Dortch K., Hunter R.E., Pine B.N., Feng J., Blount B.C., Li Y., van Bemmel D.M., Kimmel H.L., Edwards K.C., Goniewicz M.L., Hatsukami D.K., de Castro B.R., Bernert J.T., Arnstein S., Borek N., Deng-Bryant Y., Mishina E., Lawrence C., Hyland A., Hecht S.S., Conway K.P., Pirkle J.L., and Wang L. (2021).
Serum concentrations of cotinine and trans-3'-hydroxycotinine in US adults: Results from Wave 1 (2013–2014) of the Population Assessment of Tobacco and Health Study.
Nicotine and Tobacco Research.
Li Z., Hallisey E., Lewis B., Berney K., Williams A.M., Whiteman A., Rivera-González L.O., Clarke K.E.N., Clayton H., Tincher T., Opsomer J.D., Gundlapalli A., and Jones J. (2021).
Social vulnerability and rurality associated with higher SARS-CoV-2 infection-induced seroprevalence: A nationwide blood donor study, United States, July 2020 – June 2021.
Lancet.
Kasza K.A., Goniewicz M.L., Edwards K.C., Sawdey M.D., Silveira M.L., Gravely S., Zandberg I., Gardner L.D., Fong G.T., and Hyland A. (2021).
E-cigarette flavors and frequency of e-cigarette use among adult dual users who attempt to quit cigarette smoking in the United States: Longitudinal findings from the PATH Study 2015/16–2016/17.
International Journal of Environmental Research and Public Health, 18(8), 4373.
